Cargando…

Immunoglobulin G structure and rheumatoid factor epitopes

Antibodies are important for immunity and exist in several classes (IgM, IgD, IgA, IgG, IgE). They are composed of symmetric dimeric molecules with two antigen binding regions (Fab) and a constant part (Fc), usually depicted as Y-shaped molecules. Rheumatoid factors found in patients with rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Maibom-Thomsen, Sheila Lefoli, Trier, Nicole Hartwig, Holm, Bettina Eide, Hansen, Kirsten Beth, Rasmussen, Morten Ib, Chailyan, Anna, Marcatili, Paolo, Højrup, Peter, Houen, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568389/
https://www.ncbi.nlm.nih.gov/pubmed/31199818
http://dx.doi.org/10.1371/journal.pone.0217624
_version_ 1783427238222364672
author Maibom-Thomsen, Sheila Lefoli
Trier, Nicole Hartwig
Holm, Bettina Eide
Hansen, Kirsten Beth
Rasmussen, Morten Ib
Chailyan, Anna
Marcatili, Paolo
Højrup, Peter
Houen, Gunnar
author_facet Maibom-Thomsen, Sheila Lefoli
Trier, Nicole Hartwig
Holm, Bettina Eide
Hansen, Kirsten Beth
Rasmussen, Morten Ib
Chailyan, Anna
Marcatili, Paolo
Højrup, Peter
Houen, Gunnar
author_sort Maibom-Thomsen, Sheila Lefoli
collection PubMed
description Antibodies are important for immunity and exist in several classes (IgM, IgD, IgA, IgG, IgE). They are composed of symmetric dimeric molecules with two antigen binding regions (Fab) and a constant part (Fc), usually depicted as Y-shaped molecules. Rheumatoid factors found in patients with rheumatoid arthritis are autoantibodies binding to IgG and paradoxically appear to circulate in blood alongside with their antigen (IgG) without reacting with it. Here, it is shown that rheumatoid factors do not react with native IgG in solution, and that their epitopes only become accessible upon certain physico-chemical treatments (e.g. heat treatment at 57 °C), by physical adsorption on a hydrophobic surface or by antigen binding. Moreover, chemical cross-linking in combination with mass spectrometry showed that the native state of IgG is a compact (closed) form and that the Fab parts of IgG shield the Fc region and thereby control access of rheumatoid factors and presumably also some effector functions. It can be inferred that antibody binding to pathogen surfaces induces a conformational change, which exposes the Fc part with its effector sites and rheumatoid factor epitopes. This has strong implications for understanding antibody structure and physiology and necessitates a conceptual reformulation of IgG models.
format Online
Article
Text
id pubmed-6568389
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65683892019-06-20 Immunoglobulin G structure and rheumatoid factor epitopes Maibom-Thomsen, Sheila Lefoli Trier, Nicole Hartwig Holm, Bettina Eide Hansen, Kirsten Beth Rasmussen, Morten Ib Chailyan, Anna Marcatili, Paolo Højrup, Peter Houen, Gunnar PLoS One Research Article Antibodies are important for immunity and exist in several classes (IgM, IgD, IgA, IgG, IgE). They are composed of symmetric dimeric molecules with two antigen binding regions (Fab) and a constant part (Fc), usually depicted as Y-shaped molecules. Rheumatoid factors found in patients with rheumatoid arthritis are autoantibodies binding to IgG and paradoxically appear to circulate in blood alongside with their antigen (IgG) without reacting with it. Here, it is shown that rheumatoid factors do not react with native IgG in solution, and that their epitopes only become accessible upon certain physico-chemical treatments (e.g. heat treatment at 57 °C), by physical adsorption on a hydrophobic surface or by antigen binding. Moreover, chemical cross-linking in combination with mass spectrometry showed that the native state of IgG is a compact (closed) form and that the Fab parts of IgG shield the Fc region and thereby control access of rheumatoid factors and presumably also some effector functions. It can be inferred that antibody binding to pathogen surfaces induces a conformational change, which exposes the Fc part with its effector sites and rheumatoid factor epitopes. This has strong implications for understanding antibody structure and physiology and necessitates a conceptual reformulation of IgG models. Public Library of Science 2019-06-14 /pmc/articles/PMC6568389/ /pubmed/31199818 http://dx.doi.org/10.1371/journal.pone.0217624 Text en © 2019 Maibom-Thomsen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Maibom-Thomsen, Sheila Lefoli
Trier, Nicole Hartwig
Holm, Bettina Eide
Hansen, Kirsten Beth
Rasmussen, Morten Ib
Chailyan, Anna
Marcatili, Paolo
Højrup, Peter
Houen, Gunnar
Immunoglobulin G structure and rheumatoid factor epitopes
title Immunoglobulin G structure and rheumatoid factor epitopes
title_full Immunoglobulin G structure and rheumatoid factor epitopes
title_fullStr Immunoglobulin G structure and rheumatoid factor epitopes
title_full_unstemmed Immunoglobulin G structure and rheumatoid factor epitopes
title_short Immunoglobulin G structure and rheumatoid factor epitopes
title_sort immunoglobulin g structure and rheumatoid factor epitopes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568389/
https://www.ncbi.nlm.nih.gov/pubmed/31199818
http://dx.doi.org/10.1371/journal.pone.0217624
work_keys_str_mv AT maibomthomsensheilalefoli immunoglobulingstructureandrheumatoidfactorepitopes
AT triernicolehartwig immunoglobulingstructureandrheumatoidfactorepitopes
AT holmbettinaeide immunoglobulingstructureandrheumatoidfactorepitopes
AT hansenkirstenbeth immunoglobulingstructureandrheumatoidfactorepitopes
AT rasmussenmortenib immunoglobulingstructureandrheumatoidfactorepitopes
AT chailyananna immunoglobulingstructureandrheumatoidfactorepitopes
AT marcatilipaolo immunoglobulingstructureandrheumatoidfactorepitopes
AT højruppeter immunoglobulingstructureandrheumatoidfactorepitopes
AT houengunnar immunoglobulingstructureandrheumatoidfactorepitopes